Bram Laukens
Inventor
Stats
- 0 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 5 US Applications Filed
- 1 Total Citation Count
- Feb 5, 2024 Most Recent Filing
- May 3, 2017 Earliest Filing
Work History
No Work History Available.Inventor Addresses
Address | Duration |
---|---|
Gent, BE | May 16, 19 - May 14, 20 |
Ghent, BE | Mar 09, 21 - Apr 23, 24 |
Zwijnaarde, BE | Jul 07, 22 - Oct 17, 24 |
Technology Profile
Technology | Matters | |
---|---|---|
A23K: | FODDER | 1 |
A23L: | FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0343,823 | 2024 | POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR | 0 |
11964002 | 2024 | Means and methods for oral protein delivery | 0 |
11932702 | 2024 | Polypeptides comprising immunoglobulin single variable domains targeting glypican-3 and T cell receptor | 0 |
11891451 | 2024 | Glycosylation of variable immunoglobulin domains | 0 |
2022/0213,215 | 2022 | POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.